SCHEMBL23923859

SCHEMBL23923859

C=C(CCCCCCCCCC)C(CCC)CCCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.42
DNM1 Q05193 2/20 0.39
CES2 O00748 3/20 0.38
CES1 P23141 3/20 0.38
MAPK1 P28482 1/20 0.38
FFAR4 Q5NUL3 1/20 0.37
FFAR1 O14842 1/20 0.37
TSHR P16473 3/20 0.37
LMNA P02545 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
PPARG P37231 3/20 0.37
PPARD Q03181 3/20 0.37
PPARA Q07869 3/20 0.37
GPR84 Q9NQS5 2/20 0.37
HDAC11 Q96DB2 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
SLC22A6 Q4U2R8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31521547 1.00 CA2 (0.42) CA2DNM1CES2CES1MAPK1
SCHEMBL31521573 0.91 CA2 (0.40) CA2DNM1CES2CES1MAPK1
SCHEMBL25853402 0.91 CA2 (0.45) CA2CES2CES1FFAR4FFAR1
SCHEMBL31521517 0.87 CA2 (0.40) CA2DNM1MAPK1TSHRALDH1A1
SCHEMBL23923680 0.86 ACE2 (0.38) CA2MAPK1FFAR4FFAR1TSHR
SCHEMBL25949379 0.83 ALDH1A1 (0.45) CA2FFAR4FFAR1TSHRLMNA
SCHEMBL9018788 0.83 CA2 (0.42) CA2MAPK1FFAR4FFAR1LMNA
SCHEMBL23923711 0.82 CA2 (0.46) CA2MAPK1TSHRLMNAALDH1A1
SCHEMBL25949435 0.82 KDM5A (0.42) CA2DNM1FFAR4FFAR1LMNA
SCHEMBL23960194 0.81 KDM5A (0.41) CA2DNM1CES2CES1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11174205-B2 C20 2-substituted alpha olefins produced by dimerization of branched C10 olefins CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) 2021-11-16 US claimed
US-20210323892-A1 C20 2-Substituted Alpha Olefins Produced By Dimerization Of Branched C10 Olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP 2021-10-21 US claimed
WO-2025264609-A1 C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-12-26 WO disclosed
US-20250382242-A1 C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2025-12-18 US disclosed
US-11174205-B2 C20 2-substituted alpha olefins produced by dimerization of branched C10 olefins CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) 2021-11-16 US disclosed
US-20210323892-A1 C20 2-Substituted Alpha Olefins Produced By Dimerization Of Branched C10 Olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382242-A1 C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS COASY, MOGAT2, HSD17B12 CA2 1500/4885DNM1 962/4885CES2 874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.